🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the effectiveness and safety of t...
Status
Completed
Location
Gabrail Cancer Center
Start Date
2008-05
Trial ID
NCT00619099
Treatments Being Tested
This randomized phase II/III trial studies how well azacitidine with or wit...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2018-02-02
Trial ID
NCT03092674
Treatments Being Tested
This phase II trial studies the side effects of salsalate when added to ven...
Status
Completed
Location
Rutgers Cancer Institute of New Jersey
Start Date
2020-10-26
Trial ID
NCT04146038
Treatments Being Tested
This phase II trial is studying the side effects and how well decitabine wo...
Status
Completed
Location
UCSF Medical Center-Mount Zion
Start Date
2006-11-15
Trial ID
NCT00416598
The purpose of this study is to see whether giving azacitidine before each ...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2011-06
Trial ID
NCT01386346
Treatments Being Tested
This trial is designed to explore a modified dose and schedule of azacitidi...
Status
Terminated
Location
Medical & Surgical Specialists, LLC
Start Date
2006-09
Trial ID
NCT00379912
Treatments Being Tested
This phase II trial studies how well midostaurin and decitabine work in tre...
Status
Terminated
Location
Mayo Clinic
Start Date
2015-12-30
Trial ID
NCT02634827
Treatments Being Tested
This study is an open, multicenter, dose-escalation and expansion, non-rand...
Status
Not Yet Recruiting
Location
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2026-03
Trial ID
NCT07255872
Treatments Being Tested
The goal of this clinical research study is to find out if giving azacitidi...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2007-08
Trial ID
NCT00529022
Treatments Being Tested
This phase I trial studies the side effects of DEC-205/NY-ESO-1 fusion prot...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2018-03-27
Trial ID
NCT03358719